The fluoroscopy devices market consists of medical imaging devices that utilize fluoroscopy to generate real-time moving images of internal tissues, organs, bones, and blood vessels. Fluoroscopy devices offer non-invasive visualization of internal structures and dynamic movement without surgery, pain or incision. These imaging devices are beneficial for cardiologists, orthopedic and vascular surgeons in performing minimally invasive procedures with high precision.
The global fluoroscopy devices market is estimated to be valued at US$ 4720.31 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Innovations in imaging technologies is one of the key trends fueling the growth of the fluoroscopy devices market. With the technological advancements, fluoroscopy devices now offer better imaging quality, high resolution, decreased radiation dose during the procedures and simplified workflow. For instance, the new generation of fluoroscopy devices integrate digital imaging with advanced flat panel detectors that provide real-time imaging with high resolution and sensitivity. They are also equipped with dose management software that help minimize radiation exposure to critical organs. Furthermore, the miniaturization of C-arm imaging systems allowed performing minimally-invasive surgeries with improved ergonomics and mobility. These innovations simplify complex clinical procedures while ensuring maximum safety of both patients and medical professionals. This has increase the adoption rate of new fluoroscopy devices, thereby driving the market growth over the forecast period.
Segment Analysis
The global fluoroscopy devices market size is segmented by product type, application and modality. Among product type, Fixed C-arms segment dominates the market with around 50% share in 2023. Fixed C-arms segment is dominating as these devices offer high image quality to visualize soft tissues and blood vessels with high precision. Stationary C-arms have remained a backbone for operating fluoroscopy units in hospitals and healthcare facilities.
Key Takeaways
The global fluoroscopy devices market is expected to witness high growth during the forecast period. The market is projected to reach value of US$ 5345.67 Mn by 2030 from US$ 4720.31 Mn in 2023, expanding at a CAGR of 2.3%.
Regional analysis related content comprises
Geographically, North America region dominates the fluoroscopy devices market, accounting for around 40% share in 2023. This is attributed to well-established healthcare infrastructure, high awareness levels among healthcare professionals about advanced medical technologies and rising elderly population with chronic conditions in the region. Asia Pacific region is expected to witness fastest growth during forecast period owing to growing healthcare expenditure, increasing demand for minimally invasive surgeries and expanding medical tourism industry in countries like India and China.
Key players related content comprises
Key players operating in the fluoroscopy devices market are Bayer AG, Henkel AG & Co. KgaA, Avon Products Inc., Johnson & Johnson Inc., Kao Corporation, Beiersdorf AG, Groupe Clarins SA, Revlon Inc., Shiseido Co. Ltd., Unilever PLC, Procter & Gamble, Lotus Herbals Pvt. Ltd. Bayer AG and Johnson & Johnson Inc. capture around 35-40% of market share owing to their diverse product portfolio and strong global presence.
Get more insights on this topic: https://www.newsstatix.com/fluoroscopy-devices-market-share-and-opportunity-analysis-2023-2030/
Comments
0 comment